SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship

To support the development of the next generation of immunotherapy experts, this two-year award (24 months) aims to provide support for cancer immunotherapy by an individual who has an MD, PhD or combined MD/PhD degree and a vested interest in furthering the research and translation of cancer immunotherapy.

ELIGIBILITY CRITERIA

• Current SITC member, in good standing at time of submission (i.e. current in dues)
• Hold an MD, PhD or combined MD/PhD degree
• Currently hold a position at an academic institution or government cancer center as a post-doctoral fellow, resident, research scientist or comparable position, prior to obtaining a tenure track faculty position
• Be within post-doctoral or post-graduate training, or no more than four years from completing such training
• Name a pre-arranged fellowship mentor
• Submit a letter of recommendation from the mentor along with the application
• Commit 75 percent of workday to research supported by the fellowship
• Domestic and international applicants are eligible to apply

BENEFITS

• Two years, $200,000 award
• Complimentary registration and travel for SITC’s 38th Annual Meeting
• Recognition during the Award Ceremony at SITC’s 38th Annual Meeting